CIK 0001426800 · Non-accelerated filer<br>Smaller reporting company
ASSEMBLY BIOSCIENCES, INC.
Sign in to watch- Ticker
- ASMB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (833) 409-4583
- Business address
- TWO TOWER PLACE, 7TH FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- VENTRUS BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $237,648
- in 4 filings
Net −$237,648. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 89 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-29 | Samar Michael P. Chief Financial Officer | Grant or award | +26,250 | 79,033 | ||
| 2022-03-29 | Samar Michael P. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +105,000 | 105,000 | ||
| 2022-03-29 | Samar Michael P. Chief Financial Officer | Grant or award · Performance-based Restricted Stock Units | +26,250 | 26,250 | ||
| 2022-03-29 | Stamm Luisa M Chief Medical Officer | Grant or award | +22,500 | 41,353 | ||
| 2022-03-29 | Stamm Luisa M Chief Medical Officer | Grant or award · Stock Option (right to buy) | +90,000 | 90,000 | ||
| 2022-03-29 | Stamm Luisa M Chief Medical Officer | Grant or award · Performance-based Restricted Stock Units | +22,500 | 22,500 | ||
| 2022-03-29 | Delaney William E IV Chief Scientific Officer | Grant or award | +25,000 | 79,121 | ||
| 2022-03-29 | Delaney William E IV Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2022-03-29 | Delaney William E IV Chief Scientific Officer | Grant or award · Performance-based Restricted Stock Units | +25,000 | 25,000 | ||
| 2022-03-29 | Okazaki Jason A Chief Operating Officer | Grant or award | +31,250 | 95,883 | ||
| 2022-03-29 | Okazaki Jason A Chief Operating Officer | Grant or award · Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2022-03-29 | Okazaki Jason A Chief Operating Officer | Grant or award · Performance-based Restricted Stock Units | +31,250 | 31,250 | ||
| 2022-03-29 | McHutchison John G CEO and President | Grant or award | +83,750 | 209,443 | ||
| 2022-03-29 | McHutchison John G CEO and President | Grant or award · Stock Option (right to buy) | +335,000 | 335,000 | ||
| 2022-03-29 | McHutchison John G CEO and President | Grant or award · Performance-based Restricted Stock Units | +83,750 | 83,750 | ||
| 2022-03-28 | Okazaki Jason A Chief Operating Officer | Sale | −4,617 | $2.24 | $10K | 64,633 |
| 2021-08-09 | McHutchison John G CEO and President | Sale | −12,156 | $3.60 | $44K | 125,693 |
| 2021-07-22 | Samar Michael P. SVP, Fin. & Bus. Ops, PFO, PAO | Grant or award | +10,938 | 51,783 | ||
| 2021-07-19 | Houghton Michael Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2021-05-27 | Delaney William E IV Chief Scientific Officer | Sale | −4,129 | $4.03 | $17K | 53,121 |
Page 9 of 15 · 297 trades